34,805 research outputs found
Modelling surface roughening during plastic deformation of metal crystals under contact shear loading
No full textDuring plastic deformation, metal surfaces roughen and this has a deleterious impact on their tribological performance. It is therefore desirable to be able to predict and control the amount of roughening caused by subsurface plasticity. As a first step, we focus on modelling plastic deformation during contact shearing of an FCC metallic single crystal, employing a finite strain Discrete Dislocation Plasticity (DDP) formulation. This formulation allows us to capture the finite lattice rotations induced in the material by shearing and the corresponding local rotation of the crystallographic slip planes. The simulations predict a pronounced material pile-up in front of the contact and a sink-in at its rear, which are strongly crystal-orientation dependent. By comparing finite and small strain DDP, we can assess the effect of slip plane rotation on surface roughening and on metal plasticity in general. Results of the simulations are also compared with crystal plasticity, which is also capable of predicting a pile-up and sink-in, but not the crystal-orientation dependency of roughening.Accepted Author Manuscript(OLD) MSE-
The Potential Economic Impacts of the Proposed Development Corridor in Egypt: An Interregional CGE Approach
No full textEgypt has proposed a new development corridor. A main component is a desert-based expansion of the current highway network. This network is founded on a 1200-kilometer north-south route that starts at a proposed new port near El-Alemein and runs parallel to the Nile Valley to the border of Sudan. It also includes 21 east-west branches that connect the main axis to densely populated cities on the Nile. The paper is a first attempt at an economic assessment of the impact of this proposed corridor. It uses an interregional computable general equilibrium (CGE) model developed and reported in a prior paper. Here, that model is integrated with a more detailed geo-coded transportation network model to help quantify the spatial effects of transportation cost change due specifically to changes in accessibility induced by the corridor. The paper focuses on the likely structural economic impacts that such a large investment in transportation could enable through a series of simulations related to the operational phase of the project."TD NEREUS 06-2015" published by Núcleo de Economia Regional e Urbana da USP (NEREUS)
N omega-nitro-L-arginine methyl ester inhibits inflammatory liver injury induced by interleukin-2
No full textAdministration of interleukin-2 (IL-2) for treatment of metastatic disease often results in inflammatory liver injury. Previous studies have implicated increased leukocyte and platelet adhesion and enhanced nitric oxide production as causative factors in the development of IL-2-induced hepatic injury. This study investigated the capacity of N omega-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthesis inhibitor, to limit IL-2-induced hepatic edema and hepatocellular damage in mice. Using hepatic intravital microscopy, we also examined the effects of L-NAME on IL-2-induced increases in leukocyte and platelet adhesion. Administration of IL-2 increased leukocyte and platelet adhesion in post-sinusoidal venules and decreased hepatic perfusion. Cotreatment with L-NAME had no effect on leukocyte adhesion but increased platelet-endothelial adhesion and microvascular thrombosis. Chronic IL-2 treatment induced hepatic edema and hepatocellular injury. However, coadministration of L-NAME attenuated IL-2-induced edema and completely inhibited hepatocellular damage. These findings suggest that nitric oxide may play a central role in IL-2-induced inflammatory liver injury.LR: 20061115; PUBM: Print; JID: 8405628; 0 (Enzyme Inhibitors); 0 (Interleukin-2); 10102-43-9 (Nitric Oxide); 50903-99-6 (NG-Nitroarginine Methyl Ester); EC 1.14.13.39 (Nitric Oxide Synthase); EC 2.6.1.1 (Aspartate Aminotransferases); EC 2.6.1.2 (Alanine Transaminase); ppublishSource type: Electronic(1
Appropriate Similarity Measures for Author Cocitation Analysis
No full textWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Combined application of ultrasonic waves, magnetic fields and optical flow in the rehabilitation of patients and disabled people
No full textSHUPYK NATIONAL MEDICAL ACADEMY
OF POSTGRADUATE EDUCATION
PONTIFICAL CATHOLIC UNIVERSITY OF PERU
RADOM UNIVERSITY
SCM «MEDICAL INNOVATIVE TECHNOLOGIES»
Chukhraiev N., Vladimirov А., Vilcahuamаn L.,
Zukow W., Samosyuk N., Chukhraieva E., Butskaya L.
COMBINED APPLICATION OF ULTRASONIC WAVES,
MAGNETIC FIELDS AND OPTICAL FLOW IN THE REHABILITATION
OF PATIENTS AND DISABLED PEOPLE
Edited by
Chukhraiev N., Vladimirov А., Vilcahuamаn L.,
Zukow W., Samosyuk N., Chukhraieva E., Butskaya L.
КIEV, RADOM 2016
SHUPYK NATIONAL MEDICAL ACADEMY
OF POSTGRADUATE EDUCATION
PONTIFICAL CATHOLIC UNIVERSITY OF PERU
RADOM UNIVERSITY
SCM «MEDICAL INNOVATIVE TECHNOLOGIES»
Chukhraiev N., Vladimirov А., Vilcahuamаn L.,
Zukow W., Samosyuk N., Chukhraieva E., Butskaya L.
COMBINED APPLICATION OF ULTRASONIC WAVES,
MAGNETIC FIELDS AND OPTICAL FLOW IN THE REHABILITATION
OF PATIENTS AND DISABLED PEOPLE
Edited by
Chukhraiev N., Vladimirov А., Vilcahuamаn L.,
Zukow W., Samosyuk N., Chukhraieva E., Butskaya L.
КIEV, RADOM 2016
Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. Combined Application of Ultrasonic Waves, Magnetic Fields and Optical Flow in The Rehabilitation of Patients and Disabled People. Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. Eds. Shupyk National Medical Academy of Postgraduate Education. Pontifical Catholic University of Peru. Radom University. SCM «Medical Innovative Technologies». Kiev. Radom. 308 p. ISBN 9781365244537. DOI http://dx.doi.org/10.5281/zenodo.57246
UDC 615.847.8+615.837
LBC: 53.54
Reviewers:
prof. zw. dr hab. med. L. Tondiy (Ukraine), MD, Professor L. Tondiy
prof. zw. dr hab. med. V. Gubenko (Ukraine), MD, Professor V. Gubenko
prof. zw. dr hab. med. A. Kozhanova (Ukraine), MD, Professor A. Kozhanova
Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L.
Combined application of ultrasonic waves, magnetic fields and optical flow in the rehabilitation of patients and disabled people. Edited by Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. Kiev. Radom. – 2016. – 308 p.
UDC 615.847.8+615.837
LBC: 53.54
Memory
of the great scientist
Professor Ivan Zakharovich Samosyuk
dedicated.
The book presents modern data on the use of a resonant magnetic therapy, ultrasound and magnetic-laser effects. Describes practical techniques of the combined and the united use of these physical factors in the different sections of clinical medicine (neurology, cardiology, gastroenterology, gynecology, etc.).
The book also describes the modern principles of selecting impact zones, the rationale biorhythmological and resonance effects, the practical use of which is becoming increasingly important in physiotherapy and physiopuncture.
Most private techniques of magnet-laser-ultrasound therapy are described with respect to a new generation of devices of «MIT» series and the «MIT-11», which contains all three of these factors: ultrasound, magnetic field and laser radiation.
The book is intended for physical therapists, rehabilitation specialists, health resort, the doctors of narrow specialties, using methods of physiotherapy, as well as nurses rehabilitation centers, beauty parlor and a wide range of readers interested in the problems of sanitation.
Authors are grateful to Alla Tereshchenko, Yevheniya Gorlatenko and Olga Danilova for their assistance in the preparation for publication of the monograph.
© The Author(s) 2016.
This articles is published with Open Access. Medical Innovative Technologies, Kiev, Ukraine and Radomska Szkoła Wyższa w Radomiu, Poska, Radom University in Radom, Poland.
Open Access This articles is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Attribution — You must attribute the work in the manner specified by the author or licensor (but not in any way that suggests that they endorse you or your use of the work). Noncommercial — You may not use this work for commercial purposes. Share Alike — If you alter, transform, or build upon this work, you may distribute the resulting work only under the same or similar license to this one.
Zawartość jest objęta licencją Creative Commons Uznanie autorstwa-Użycie niekomercyjne-Na tych samych warunkach 3.0
Publishing House: Radomska Szkoła Wyższa w Radomiu, Radom University in Radom Str. Zubrzyckiego 2 26-600 Radom Tel.: +48 48 383 66 05 [email protected]
Printing House: Radomska Szkoła Wyższa w Radomiu, Radom University in Radom Str. Zubrzyckiego 2 26-600 Radom Tel.: +48 48 383 66 05 [email protected]
ISBN 9781365244537
DOI http://dx.doi.org/10.5281/zenodo.57246
308 s. Liczba znaków: 478 000 (ze streszczeniami i okładką). Liczba grafik: 136 x 1 000 znaków (ryczałt) = 136 000 znaków.
Razem: Liczba znaków: 614 000 (ze streszczeniami, okładką i grafikami) = 15,35 arkuszy wydawniczych.
308 p. Number of characters: 248 000 (with abstracts). Number of images: 136 x 1000 characters (lump sum) = 136 000 characters.
Total: Number of characters: 614 000 (with abstracts, summaries and graphics) = 15,35 sheet publications.
CONTENT
ABBREVIATIONS............................................................................................. 8
INTRODUCTION............................................................................................... 9
Modern principles of choice of impact zones in the physiotherapy treatment..... 10
Lets speak more detail on the possible areas of choice for PT................................ 10
Zones of Zakhary’in-Ged and metameric segmental principle
of choosing zones in physiotherapy...................................................................... 11
The systemic principle of the human body functions organization
and the selection of treatment zones, based on this principle.............................. 15
Special and specific zones of influence and choice in
the practice of physical therapy............................................................................ 21
Lumbar region...................................................................................................... 21
The area of cervical spine...................................................................................... 21
The trans-cerebral techniques............................................................................... 22
Biological rhythms and bioresonance therapy...................................................... 26
Ultrasound therapy............................................................................................... 47
Basic terms and concepts...................................................................................... 49
Features of action of ultrasonic waves on the body............................................... 52
The therapeutic effect of ultrasound waves*........................................................ 53
The methods and techniques of treatment with ultrasonic waves........................ 57
Ultrasound therapy (UST).................................................................................... 58
Ultraphonophoresis (UPPh)................................................................................. 58
Sonopuncture (SP)............................................................................................... 61
A combination of other health factors with sonopuncture................................... 65
The combination of the action of ultrasonic waves with other physical factors ... 65 Indications and contraindications to the use of ultrasound therapy.............................................. 66
The main indications for ultrasound therapy........................................................ 66
Main contraindications......................................................................................... 67
Prohibited areas for ultrasonic therapy................................................................. 67
Features of ultrasound therapy............................................................................. 68
Nota bene for doctor and patient......................................................................... 69
Magnetic-laser therapy......................................................................................... 69
Therapeutic effects of magnetic laser therapy (MLT)........................................... 72
General principles of magneto-laser therapy........................................................ 78
Here are some options for MLT and features of their use.................................... 79
Percutaneous magnetic laser irradiation of blood................................................ 80
The zone for exposure to magnetic percutaneous laser irradiation of the blood . 82 Parameters of the procedure of hemo-magnetic-laser-therapy........................................................................... 82
The combined and united use of physical factors.................................................. 84
REFERENCES.................................................................................................... 88
PRACTICAL RECOMMENDATIONS FOR USE OF MAGNET-LASER-ULTRASOUND THERAPY IN CLINICAL
PRACTICE AND THE SPA ................................................................................
Contraindications................................................................................................. 92
К00-К93 Diseases of the digestive system........................................................... 94
K50-K52 NONINFECTIOUS Enterocolitis and colitis...................................... 94
K29 GASTRITIS, DUODENITIS...................................................................... 96
K25 Gastric ulcer.................................................................................................. 98
K26 Duodenal Ulcer............................................................................................ 98
K71 LIVER TOXICITY..................................................................................... 100
К70 K70 CHRONIC HEPATITIS..................................................................... 102
К82.8 DYSKINESIA OF CYSTIC DUCT OR GALLBLADDER.................... 104
К 86.0 CHRONIC PANCREATITIS................................................................. 106
K81 CHOLECYSTITIS (non-calculous)............................................................ 108
К 59.0 CONSTIPATION (Other functional intestinal disorders)...................... 110
J00-J99 RESPIRATORY DISEASES............................................................................... 112
A15-A19 PULMONARY TUBERCULOSIS.................................................... 112
J42 CHRONIC BRONCHITIS UNSPECIFIED.............................................. 114
J18 PNEUMONIA............................................................................................. 116
J.45 BRONCHIAL ASTHMA............................................................................ 118
J01 ACUTE SINUSITIS (ANTRITIS)............................................................... 120
J01 ACUTE SINUSITIS (FRONTAL SINUSITIS)........................................... 122
J03 ACUTE TONSILLITIS................................................................................ 124
J00 ACUTE NASOPHARYNGITIS (RHINITIS)............................................. 126
J31.2 CHRONIC PHARYNGITIS.................................................................... 128
J37 CHRONIC LARYNGITIS AND TRACHEITIS......................................... 130
Н65- Н66 CHRONIC SUPPURATIVE OTITIS MEDIA................................ 132
H81.0 MÉNIÈRE’S DISEASE, SENSORINEURAL HEARING LOSS...................................... 134
K00-K14 DISEASES OF ORAL CAVITY,....................................................... 136
SALIVARY GLANDS AND JAWS......................................................................................... 136
М19.2- М24.6 ARTHROSIS OF THE TEMPOROMANDIBULAR JOINT..... 138
N00-N99 DISEASES OF THE GENITOURINARY SYSTEM........................ 140
F98 ENURESIS.................................................................................................. 140
N48.4 IMPOTENCE.......................................................................................... 142
N41.1 CHRONIC PROSTATITIS..................................................................... 144
N34 URETHRITIS AND URETHRAL SYNDROME...................................... 146
N11 CHRONIC PYELONEPHRITIS............................................................... 148
N20-N23 UROLITHIASIS................................................................................ 150
O00-O99 PREGNANCY, CHILDBIRTH AND THE PUERPERIUM........... 152
O92.1 CRACKED NIPPLES............................................................................. 152
MAIN POINTS OF ACUPUNCTURE IN GYNECOLOGY........................... 154
N61 MASTITIS................................................................................................. 154
N70.1 CHRONIC ADNEXITIS........................................................................ 156
N71 ENDOMETRITIS...................................................................................... 158
N94 ALGOMENORRHEA............................................................................... 160
N91.0- N91.1 AMENORRHEA........................................................................ 162
N73 INFLAMMATORY DISEASES OF THE PERITONEUM
AND TISSUES OF THE SMALL PELVIS...................................................... 164
N86 CERVICAL EROSION............................................................................. 166
N90.5 KRAUROSIS OF THE VULVA.................................................................................. 168
N89 VAGINAL DISCHARGE......................................................................... 170
N97 INFERTILITY........................................................................................... 172
О12- О14- О15 GESTATIONAL TOXICOSIS (GESTOSES)......................... 174
I99 DISEASES OF THE CIRCULATORY SYSTEM................................ 176
I10 HYPERTENSIVE HEART DISEASE....................................................... 176
I22 MYOCARDIAL INFARCTION................................................................ 178
I49 EXTRASYSTOLE (OPTION 1).................................................................. 180
I49 EXTRASYSTOLE (OPTION 2).................................................................. 182
E10-E14 DIABETES.......................................................................................... 184
I20-I25 CORONARY HEART DISEASE........................................................ 186
E06.3 AUTOIMMUNE THYROIDITIS........................................................... 189
I63 ISCHEMIC STROKE................................................................................. 191
G43 MIGRAINE............................................................................................... 194
N00-H59 DISEASES OF THE EYE AND ADNEXA...................................... 196
H47.0 OPTIC NERVE SUBATROPHY.......................................................... 196
H35 RETINITIS PIGMENTOSA...................................................................... 196
H00-H59 MYOPIA............................................................................................ 198
Н 36.0 DIABETIC RETINOPATHY................................................................ 200
L00-L99 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE....... 203
L40 PSORIASIS................................................................................................ 203
L43 RED FLAT ZOSTER.................................................................................. 205
L20-L30 DERMATITIS AND ECZEMA......................................................... 207
B00 B00 INFECTION CAUSED BY THE HERPES VIRUS
(HERPES SIMPLEX)........................................................................................ 210
L20.8 NEURODERMATITIS........................................................................... 212
L94.0 LOCALIZED SCLERODERMA............................................................ 214
SURGICAL DISEASES.................................................................................... 216
К65 PERITONITIS........................................................................................... 216
L91.0 KELOIDS (PREVENTION SUPPURATION)...................................... 218
T79.3 POST-TRAUMATIC WOUND INFECTION,
NOT ELSEWHERE CLASSIFIED................................................................... 220
FESTERING WOUNDS................................................................................... 220
L02 ABSCESSES, BOILS, CARBUNCLES.................................................... 222
L03 PHLEGMON, FELON............................................................................... 222
E14.5 TROPHIC ULCERS................................................................................ 224
I80 PHLEBITIS AND THROMBOPHLEBITIS.............................................. 226
А46 ERYSIPELAS............................................................................................ 228
T20-T32 THERMAL AND CHEMICAL BURNS............................................ 230
M42 OSTEOCHONDROSIS............................................................................ 232
M54.4 4 LUMBAGO WITH SCIATICA.......................................................... 234
R52 CHRONIC PAIN SYNDROME................................................................ 236
M60.0 MYO FASCIITIS................................................................................... 238
M62.8 MIOFIBROZIT...................................................................................... 238
M79.0 FIBROSIS; FIBROMYALGIA;............................................................ 238
M72.5 FASCIITIS.............................................................................................. 238
M00-M99 DISEASES OF THE MUSCULOSKELETAL
SYSTEM AND CONNECTIVE TISSUE......................................................... 240
M 00 - M 03 INFECTIOUS ARTHROPATHIES............................................. 240
M05-M14 INFLAMMATORY POLYARTHROPATHIES............................. 242
(RHEUMATOID ARTHRITIS)........................................................................ 242
М15-М 19 DEFORMING ARTHROSIS.......................................................... 244
М10-М14 ARTHRITIS GOUTY....................................................................... 246
K07 DISEASES OF THE TEMPOROMANDIBULAR JOINT....................... 248
K07.6 CALCANEAL SPUR.............................................................................. 250
М 65.2 CALCIFYING TENDOVAGINITIS................................................... 252
М45. BEKHTEREV’S DISEASE (ANKYLOSING SPONDYLITIS)............ 254
M24 DUPUYTREN’S CONTRACTURE......................................................... 256
M81 OSTEOPOROSIS...................................................................................... 258
G00-G99 DISEASES OF THE NERVOUS SYSTEM...................................... 260
G51 NEURITIS OF THE FACIAL NERVE..................................................... 260
G50 DAMAGE OF THE TRIGEMINAL NERVE........................................... 262
Ultrasound puncture........................................................................................... 264
М79.2 INTERCOSTAL NEURALGIA............................................................ 265
Ultrasound puncture........................................................................................... 267
M79.2 NEURALGIA OF CERVICAL DEPARTMENT OF THE BACKBONE .. 268 M79.2 NEURALGIA OF THE LUMBAR SPINE...................................................................................... 270
Т75.2 VIBRATION DISEASE.......................................................................... 272
M60 MYOSITIS................................................................................................. 274
ULTRASONIC PUNCTURE IN MYOSITIS:.................................................. 275
F00-F99 MENTAL AND BEHAVIORAL DISORDERS................................ 276
F51.0 INSOMNIA............................................................................................. 276
F32 DEPRESSION............................................................................................ 278
F40-F48 NEUROTIC, STRESS-RELATED AND
SOMATOFORM DISORDERS........................................................................ 280
Е65-Е68 OBESITY AND OTHER TYPES OF HYPERNUTRITION............. 282
F01.1 MULTI-INFARCT DEMENTIA............................................................. 284
I 15 VEGETATIVE DYSTONIA (VD) ON HYPERTENSIVE TYPE............ 286
G21 PARKINSON’S DISEASE........................................................................ 288
F90 DYSTONIC HYPERKINESIA (TORTICOLLIS,.................................... 290
OROMANDIBULAR DYSKINESIA)............................................................. 290
APPLICATION OF MAGNET-LASER ULTRASOUND
THERAPY FOR HEALTH IMPROVING AND PREVENTIVE PURPOSES 292
Annex 1..
L-Valine derived chiral N-sulfinamides as effective organocatalysts for the asymmetric hydrosilylation of N-alkyl and N-aryl protected ketimines
No full textL-Valine derived N-sulfinamides have been developed as efficient enantioselective Lewis basic organocatalysts for the asymmetric reduction of N-aryl and N-alkyl ketimines with trichlorosilane. Catalyst 3c afforded up to 99% yield and 96% ee in the reduction of N-alkyl ketimines and up to 98% yield and 98% ee in the reduction of N-aryl ketimines
The vanishing author in computer-generated works: a critical analysis of recent Australian case law
No full textAbstract
The use of software is ubiquitous in the creation of many copyright works, yet the requirement in copyright law that every work have a human author who engages in independent intellectual effort means that its use may prevent copyright subsistence. Several recent Australian cases have refocused attention on authorship as an essential criterion of copyright subsistence, and these cases suggest that much computer-produced output may be authorless and thus lack copyright protection. This article, the first in a two-part series, analyses how each case deals with the question of authorship of computer-produced works and why the use of software diminishes copyright protection for a significant number of computer-generated works. The article critiques the application of conventional notions of human authorship developed in the pre-computer age to modern productions and suggests alternative approaches to authorship that satisfy both the major objectives of copyright policy and the need to adapt to the computer age. The article argues that, without a broader judicial approach to authorship of computer-generated works, Parliament must remedy the lacuna in protection for these ‘authorless’ works. Possible solutions for reform are suggested. In a forthcoming article, the author comprehensively examines those reform proposals
Ratio of n-6/n-3 in the diets of beef cattle
No full textEffects of feeding heat-treated canola (C), soybean (S) and flax (F) or mixtures on growth and slaughter characteristics, taste and fatty acid (FA) composition of beef tissue were investigated using 128 crossbred steers to determine the potential of improving the nutritional quality of beef for humans. For Trial 1 (48 steers), dietary treatments were: roasted C, extruded C, roasted S, extruded S, roasted F and extruded F. For Trial 2 (80 steers), the dietary treatments were: S:F (1:1), S:C (1:1), C:F (1:1) and S:F:C (1:1:1), and the oilseeds were processed either by roasting or extruding before mixing. Soybean meal and soybean oil were used to give equivalent lipid and protein contents to each experimental diet. The basal diet consisted of grass silage, barley grain, vitamins and minerals. Steers were fed for a minimum of 100d then slaughtered at a uniform degree of finish. Growth and slaughter characteristics of the steers were only slightly affected by dietary treatment in that the soybean-fed steers consumed more feed and had a higher average daily gain than the canola or flax-fed animals in Trial 1. There was no difference in taste panel parameters for any of the treatments. Inclusion of flax in the diet increased the total n-3 content of meat. Similar results were found for canola and C18:1n-9 although this was not the case for soybean and the n-6 FA. For the n-6 FA in the PL and neutral lipid fractions of the meat samples, levels were correlated with high dietary levels of n-6 or n-9 with low levels of n-3 while for the n-3 FA, levels were correlated with high dietary n-3 levels and low n-6 levels. Oilseed processing method did not have an effect on any fatty acid levels. It is possible to modify the FA composition of beef meat toward a healthier profile by including heat-treated oilseeds in the diet to influence the degree of lipid metabolism in the rumen.ID: S0377840111004007; M3: Article; Accession Number: S0377840111004007; Author: M.A. McNiven (a, ⁎); Author: J.L. Duynisveld (b); Author: T. Turner (a); Author: A.W. Mitchell (a); Affiliation: Department of Health Management, Atlantic Veterinary College, University of PEI, Charlottetown, PEI, Canada C1A 4P3; Affiliation: Agriculture and Agri-Food Canada, Nappan, NS, Canada B0L 1C0; Keyword: Oilseeds; Keyword: Roasted; Keyword: Extruded; Keyword: Fatty acids; Keyword: Healthy fat; Number of Pages: 11; Language: English
Informetrics on M. N. Srinivas
No full textM. N. Srinivas, the well known sociologist is widely recognised as architect of modern Indian sociology and social anthropology. His publications have been analysed by year, domain, authorship pattern, channels of communication used. Keywords, etc. The results indicate that the papers published by him are of a nature that qualify him to be a 'role model' for the younger generations to emulate.
By the end of 1995, Srinivas had to his credit 144 papers which, included 33 broad papers in sociology and anthropology; 18 papers in social change; 28 papers in village studies; 12 papers on religion; 17 papers on caste and 36 papers of general popular interest. The periods 1958-61 and 1974-77, when Srinivas was 38-41 and 58-61 years old. were his most productive periods with highest publication activity
- …
